SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?


To: Sir Auric Goldfinger who wrote (771)4/1/2000 11:33:00 PM
From: sommovigo  Read Replies (2) | Respond to of 3392
 
Orek - I am hereby forwarding what I believe to be your slanderous and defaming post to CYBR's attorney as I believe that, once again, you have publicly lied on a bulletin board and in my opinion I suspect that you have done it in order to manipulate public sentiment so that you may more effectively short-sell against CYBR.



To: Sir Auric Goldfinger who wrote (771)4/1/2000 11:44:00 PM
From: glenairlie  Read Replies (1) | Respond to of 3392
 
Auric, like I said, the deal was only inked about 1 week ago (3/22)
and it is month-end and year-end time for Cyber-Care. Relax. Why so hostile?
This is just business, after all. You seem to take this all so personally.
You will end up with a cardiac arrest.

As for revenues, the EHC division will not start genererating serious revenues until
later in the year, and the other divisions are mostly profitable, from my understanding.

Actually, Morrell has turned the company around, with revenues nearly
tripling since 1998, as you can see below:

THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
(UNAUDITED) (UNAUDITED)

1999 1998 1999 1998
------------ ------------ ------------ ------------
Income:
Revenue from operations ................ $ 10,772,612 $ 3,678,198 $ 27,520,587 $ 11,025,372
Equity in net income of investee ....... -- 78,984 90,300 136,413
Gain on sale of investment in equity
securities ........................... 76,790 -- 76,790 --
Gain on sale of subsidiary ............. -- -- 1,255,959 --
------------ ------------ ------------ ------------
Total income ................ 10,849,402 3,757,182 28,943,636 11,161,785
------------ ------------ ------------ ------------
Expenses:
Cost of revenues ....................... 6,394,024 1,443,532 15,497,641 5,358,301
General and administrative expenses .... 2,834,749 1,372,033 7,956,812 3,434,496
Depreciation and amortization .......... 766,770 545,687 2,080,985 951,123
Interest expense, net .................. 486,603 295,376 1,665,480 642,250
Interest - beneficial conversion feature 132,156 -- 884,289 --
------------ ------------ ------------ ------------
Total expenses .............. 10,614,302 3,656,628 28,085,207 10,386,170
------------ ------------ ------------ ------------

Income from continuing operations ............ 235,100 100,554 858,429 775,615
Merger costs ................................. -- 117,748 -- 117,748
Loss from discontinued operations ............ -- 1,476,098 -- 1,598,704
Loss from disposal of discontinued operations -- 678,529 -- 678,529
------------ ------------ ------------ ------------
Net income (loss) ............................ 235,100 (2,171,821) 858,429 (1,619,366)

Accumulated deficit-beginning of periods ..... (27,020,016) (19,709,936) (27,643,345) (20,262,391)
------------ ------------ ------------ ------------
Accumulated deficit-end of periods............ $(26,784,916) $(21,881,757) $(26,784,916) $(21,881,757)
------------ ------------ ------------ ------------

Earnings (loss) per share of common stock:
Basic earnings per share:
Income from continuing operations $ .01 $ .01 $ .03 $ .04
Discontinued operations .......... $ -- $ (.12) $ -- $ (.13)
------------ ------------ ------------ ------------
Net income (loss) ................ $ .01 $ (.11) $ .03 $ (.09)
============ ============ ============ ============
Diluted earnings (loss) per share .... $ .01 $ (.11) $ .03 $ (.09)
============ ============ ============ ============

Weighted average shares outstanding:
Basic ................................. 30,752,747 19,472,557 26,058,396 18,398,760
============ ============ ============ ============
Diluted ............................... 35,793,678 19,472,557 30,149,801 18,398,760
============ ============ ============ ============